IP Library › Granted Patent US 11,623,939
Granted Patent B2
US 11,623,939 · App. 17/267,790 · Granted Apr 11, 2023

All-trans polyene amphoteric macrolide

Inventors: Alexander Lucia Leonardus Duchateau (Echt, NL); Peter Philip Lankhorst (Echt, NL); Willebrordus Bernardus Van Scheppingen (Echt, NL)
Assignee: DSM IP ASSETS B.V.
C07H17/08C07H1/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,623,939
App. No.
17/267,790
Granted
Apr 11, 2023
Kind
B2
Abstract

The present invention is directed to a process for purifying natamycin, to an all-trans polyene amphoteric macrolide, to a composition comprising said polyene amphoteric macrolide and to a process for preparing said polyene amphoteric macrolide.

Claims (2)

1. A compound comprising (1R,3S,5E,7R,11R,13E,15E,17E,19E,21R,23S,24R,25S)-21-[(3-Amino-3,6-dideoxy-β- D -mannopyranosyl)oxy]-1,3,7,25-tetrahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo-[21.3.1]heptacosa-5,13,15,17,19-pentaene-24-carboxylic acid of formula (II) or a salt thereof

2. A composition comprising natamycin, water and the compound or salt according to claim 1 wherein the amount of water is from 0.001-10% (w/w) and wherein the amount of said compound or salt according to claim 1 is from 0.001-0.1% (w/w) relative to the amount of natamycin.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 10, 2021
From: DUCHATEAU, ALEXANDER LUCIA LEONARDUS; LANKHORST, PETER PHILIP; VAN SCHEPPINGEN, WILLEBRORDUS BERNARDUS
To: DSM IP ASSETS B.V.
Reel/Frame 055221/0061 →
Priority Claims (1)
EP 18189251 · Aug 16, 2018 · regional
Continuity (1)
Related Publication 20210230207A1 · Jul 29, 2021